10 Best US Stocks to Buy Under $50

8. Legend Biotech Corporation (NASDAQ:LEGN)

Stock Price: $19.13

Stock Upside Potential: 197.11%

Number of Hedge Fund Holders: 28

Legend Biotech Corporation (NASDAQ:LEGN) is one of the best US stocks to buy under $50. On January 15, analysts at Deutsche Bank reiterated a Buy rating on Legend Biotech Corporation (NASDAQ:LEGN) and set a $60 price target. The positive stance comes amid expectations that the company will deliver topline results from its first in-vivo CAR T program for patients before the end of the year.

Initial preclinical data have already shown robust dose-dependent CAR-T expansion in non-human primates. The data have also demonstrated sustained peripheral B-cell elimination from day 8 to day 36. The data suggest that in vivo CAR-T cells exhibit properties similar to those of traditional CAR-T treatments.

Amid the expected positive clinical trial results, Legend Biotech has also reiterated plans to achieve profitability in 2026. Profitability would come even as the company focuses on developing its pipeline, focusing on in vivo and allogeneic CAR-T therapies.

Similarly, Cantor Fitzgerald has also reiterated its bullish stance on the stock. On December 17, the research firm reaffirmed an Overweight rating on the stock and a $74 price target. According to the research firm, the company’s cancer therapy, Carvykti, is on track to deliver a 100% year-over-year increase in sales to $2 billion. The company’s partner, Johnson & Johnson, expects Carvykti’s peak sales to exceed $5 billion in the rapidly growing multiple myeloma market.

Legend Biotech Corporation (NASDAQ:LEGN) is a global clinical-stage biotechnology company focused on discovering, developing, and commercializing novel cell therapies, primarily for cancer (oncology) and other severe diseases. It leverages technologies such as CAR-T cell therapy to create personalized treatments, including its successful CARVYKTI for multiple myeloma, and works with partners such as Johnson & Johnson.